SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-07-113977
Filing Date
2007-05-15
Accepted
2007-05-14 19:07:25
Documents
2
Period of Report
2007-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT NO. 1 d8ka.htm 8-K/A 16433
2 REVISED STATEMENTS OF OPERATIONS AND NON-GAAP RECONCILIATION dex993.htm EX-99.3 142459
  Complete submission text file 0001193125-07-113977.txt   160502
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19756 | Film No.: 07848612
SIC: 2836 Biological Products, (No Diagnostic Substances)